AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 262 min read$GL

Alston Cheryl sold $1.5M of GL

Alston Cheryl sold 8,258 shares of GLOBE LIFE INC. (GL) at an average of $179.24 ($177.56–$180.57, $1.48M total) across 4 trades on 2026-06-25.

Original reporting
SEC EDGAR · Alston Cheryl
Published Jun 26, 2026, 7:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 7:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$GL
Neutral
medium confidence
Mentioned
$GL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GLNeutralLow
01

Why it matters

The disclosure updates the insider activity record and may slightly influence sentiment, but it does not introduce new operating or financial information about Globe Life.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to materially reprice the stock.

03

What to watch

No 10b5-1 plan is indicated, but the article also provides no context on prior holdings, compensation, or whether the sale was part of a longer-term pattern.

Relevance 6/10Novelty 5/10Timing: after-hours/filing date (2026-06-26) for a 2026-06-25 sale

Background

This is an SEC Form 4 insider transaction disclosure for Globe Life director Alston Cheryl.

Company-level read

Ticker impact

$GLNeutralMedium confidence
Context

Globe Life Form 4 shows director Alston Cheryl sold $1.48M of GL shares in open-market trades on 2026-06-25.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deal, or investigation).

Market effects

Sector

None; this is company-specific insider transaction data with no sector-wide catalyst.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

The sale could be liquidity-driven (taxes, diversification, planned spending) and may not reflect a bearish view, especially without evidence of a broader negative catalyst.

Key entities

  • issuer
    GLOBE LIFE INC.

    Subject of the Form 4 insider transaction; director sold shares totaling ~$1.48M.

  • insider
    Alston Cheryl

    Director who executed open-market sales of GL shares on 2026-06-25.

Read at source← All news

Related articles

JUL 25
$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

sekbernews.id4 min
JUL 23
$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

financialcontent.com6 min
JUL 23
$GLMedAI 8/10

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

benzinga.com10 min
JUL 23
$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

finance.yahoo.com6 min
JUL 23
$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

investing.com4 min
JUL 22
$GLMed

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with

SEC EDGAR 8-K6 min